|
Volumn 46, Issue 11, 2011, Pages 5698-5704
|
2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)
|
Author keywords
5 Hydroxychromone; 5 Hydroxyflavone; Aryl diketoacid (ADK); Hepatitis C; Severe Acute Respiratory Syndrome (SARS)
|
Indexed keywords
1 [3 (3 CHLORO BENZYLOXY) 6 HYDROXY 2 METHOXY PHENYL] ETHANONE;
2 ARYLMETHYLOXY 6 (3 CHLORO BENZYLOXY) 5 HYDROXY CHROMEN 4 ONE;
2 ARYLMETHYLOXY 6 (3 CHLORO BENZYLOXY) 5 METHOXY CHROMEN 4 ONE;
2 BENZYLOXY 6 (3 CHLORO BENZYLOXY) 5 HYDROXY CHROMEN 4 ONE;
2 BENZYLOXY 6 (3 CHLORO BENZYLOXY) 5 METHOXY CHROMEN 4 ONE;
2,6 BIS (3 CHLORO BENZYLOXY) 5 METHOXY CHROMEN 4 ONE;
2,6 BIS ARYLMETHYLOXY 5 HYDROXYCHROMONE;
2,6 BIS(3 CHLORO BENZYLOXY) 5 HYDROXY CHROMEN 4 ONE;
3 [6 (3 CHLORO BENZYLOXY) 5 HYDROXY 4 OXO 4H CHROMEN 2 YLOXYMETHYL] BENZONITRILE;
3 [6 (3 CHLORO BENZYLOXY) 5 METHOXY 4 OXO 4H CHROMEN 2 YLOXYMETHYL] BENZONITRILE;
6 (3 CHLORO BENZYLOXY) 2 (3 IODO BENZYLOXY) 5 METHOXY CHROMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 2 (3,5 DICHLORO BENZYLOXY) 5 HYDROXY CHORMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 2 (3,5 DICHLORO BENZYLOXY) 5 HYDROXY CHROMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 2 (3,5 DICHLORO BENZYLOXY) 5 METHOXY CHROMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 2 (4 CHLORO BENZYLOXY) 5 HYDROXY CHROMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 2 (4 CHLORO BENZYLOXY) 5 METHOXY CHROMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 2 (4 IODO BENZYLOXY) 5 METHOXY CHROMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 2 METHANESULFONYL 5 METHOXY CHROMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 5 HYDROXY 2 (3 IODO BENZYLOXY) CHROMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 5 HYDROXY 2 (3 IODOBENZYLOXY) CHROMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 5 HYDROXY 2 (4 IODO BENZYLOXY) CHROMEN 4 ONE;
6 (3 CHLORO BENZYLOXY) 5 METHOXY 2 METHYLSULFANYL CHROMEN 4 ONE;
ADENOSINE TRIPHOSPHATASE;
ANTIVIRUS AGENT;
UNCLASSIFIED DRUG;
ANTIVIRAL ACTIVITY;
ARTICLE;
BINDING SITE;
CELL VIABILITY;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
HEPATITIS C VIRUS;
HUMAN;
HUMAN CELL;
HYDROPHOBICITY;
IC 50;
SARS CORONAVIRUS;
STRUCTURE ACTIVITY RELATION;
VIRUS INHIBITION;
VIRUS REPLICATION;
VIRUS VIABILITY;
ANTIVIRAL AGENTS;
CELL LINE, TUMOR;
CHROMONES;
HEPACIVIRUS;
HUMANS;
INHIBITORY CONCENTRATION 50;
SARS VIRUS;
|
EID: 80054944870
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2011.09.005 Document Type: Article |
Times cited : (59)
|
References (16)
|